Kapitalo Investimentos Ltda Laboratory Corp Of America Holdings Transaction History

Kapitalo Investimentos Ltda

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$209.01 - $232.56 $136,692 - $152,094	654 Added 98.49%	1,318 $288 Million
Q4 2023 Mar 29, 2024	SELL	$197.69 - $227.29 $672,541 - $773,240	-3,402 Reduced 83.67%	664 $151 Million
Q3 2023 Mar 29, 2024	BUY	$201.05 - $221.7 $817,469 - $901,432	4,066 New	4,066 $817 Million
Q2 2023 Mar 29, 2024	SELL	$211.93 - $241.33 $97,063 - $110,529	-458 Closed	0 $0
Q1 2023 Mar 29, 2024	BUY	$213.32 - $257.83 $97,700 - $118,086	458 New	458 $90.3 Million

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $21.5B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Kapitalo Investimentos Ltda with notifications on news.